Harmony Biosciences Holdings, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harmony Biosciences Holdings, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.4M, a 43.9% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.7M, a 39.2% increase year-over-year.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $31.2M, a 16% increase from 2022.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.9M, a 67.1% increase from 2021.
  • Harmony Biosciences Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.1M, a 210% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $31.2M +$4.3M +16% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $26.9M +$10.8M +67.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $16.1M +$10.9M +210% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $5.19M -$4.72M -47.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $9.91M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.